Skewed X-inactivation is common in the general female population

X-inactivation is a well-established dosage compensation mechanism ensuring that X-chromosomal genes are expressed at comparable levels in males and females. Skewed X-inactivation is often explained by negative selection of one of the alleles. We demonstrate that imbalanced expression of the paternal and maternal X-chromosomes is common in the general population and that the random nature of the X-inactivation mechanism can be sufficient to explain the imbalance. To this end, we analyzed blood-derived RNA and whole-genome sequencing data from 79 female children and their parents from the Genome of the Netherlands project. We calculated the median ratio of the paternal over total counts at all X-chromosomal heterozygous single-nucleotide variants with coverage ≥10. We identified two individuals where the same X-chromosome was inactivated in all cells. Imbalanced expression of the two X-chromosomes (ratios ≤0.35 or ≥0.65) was observed in nearly 50% of the population. The empirically observed skewing is explained by a theoretical model where X-inactivation takes place in an embryonic stage in which eight cells give rise to the hematopoietic compartment. Genes escaping X-inactivation are expressed from both alleles and therefore demonstrate less skewing than inactivated genes. Using this characteristic, we identified three novel escapee genes (SSR4, REPS2, and SEPT6), but did not find support for many previously reported escapee genes in blood. Our collective data suggest that skewed X-inactivation is common in the general population. This may contribute to manifestation of symptoms in carriers of recessive X-linked disorders. We recommend that X-inactivation results should not be used lightly in the interpretation of X-linked variants

Systemic antimicrobial therapy in foals

Antimicrobial agents are commonly used in neonatal foals for the treatment or prevention of sepsis. However, due to concerns about the development of antimicrobial resistance and increasing pressure on veterinarians to rationalise antimicrobial use, we should be trying to reduce the unnecessary use of antimicrobials. This article reviews many of the important considerations when selecting an antimicrobial for use in neonatal foals. Firstly, we consider general differences in neonatal pharmacology and physiology. Secondly, we review common antimicrobial drugs and their indications. Finally, we review antimicrobial stewardship

Systemic antimicrobial therapy in foals

Antimicrobial agents are commonly used in neonatal foals for the treatment or prevention of sepsis. However, due to concerns about the development of antimicrobial resistance and increasing pressure on veterinarians to rationalise antimicrobial use, we should be trying to reduce the unnecessary use of antimicrobials. This article reviews many of the important considerations when selecting an antimicrobial for use in neonatal foals. Firstly, we consider general differences in neonatal pharmacology and physiology. Secondly, we review common antimicrobial drugs and their indications. Finally, we review antimicrobial stewardship

Global greenhouse gas implications of land conversion to biofuel crop cultivation in arid and semi-arid lands - Lessons learned from Jatropha

Biofuels are considered as a climate-friendly energy alternative. However, their environmental sustainability is increasingly debated because of land competition with food production, negative carbon balances and impacts on biodiversity. Arid and semi-arid lands have been proposed as a more sustainable alternative without such impacts. In that context this paper evaluates the carbon balance of potential land conversion to Jatropha cultivation, biofuel production and use in arid and semi-arid areas. This evaluation includes the calculation of carbon debt created by these land conversions and calculation of the minimum Jatropha yield necessary to repay the respective carbon debts within 15 or 30 years. The carbon debts caused by conversion of arid and semi-arid lands to Jatropha vary largely as a function of the biomass carbon stocks of the land use types in these regions. Based on global ecosystem carbon mapping, cultivated lands and marginal areas (sparse shrubs, herbaceous and bare areas) show to have similar biomass carbon stocks (on average 4-8 t C ha -1) and together cover a total of 1.79 billion ha. Conversion of these lands might not cause a carbon debt, but still might have a negative impact on other sustainability dimensions (e.g. biodiversity or socio-economics). Jatropha establishment in shrubland (0.75 billion ha) would cause a carbon debt of 24-28 t C ha -1 on average (repayable within 30 year with yield of 3.5-3.9 t seed ha -1 yr -1). Land use change in the 1.15 billion ha of forested area under arid and semi-arid climates could cause a carbon debt between 70 and 118 t C ha -1. This debt requires 8.6-13.9 t seed production ha -1 yr -1 for repayment within 30 years. If repayment is required within 15 years, the necessary minimum yields almost double. Considering that 5 t seed ha -1 yr -1 is the current maximum Jatropha yield, conversion of forests cannot be repaid within one human generation. Repayment of carbon debt from shrubland conversions in 30 years is challenging, but feasible. Repayment in 15 year is currently not attainable. Based on this analysis the paper discusses the carbon mitigation potential of biofuels in arid and semi-arid environments. © 2012 Elsevier Ltd. All rights reserved.info:eu-repo/semantics/publishe

Systemic antimicrobial therapy in foals

Antimicrobial agents are commonly used in neonatal foals for the treatment or prevention of sepsis. However, due to concerns about the development of antimicrobial resistance and increasing pressure on veterinarians to rationalise antimicrobial use, we should be trying to reduce the unnecessary use of antimicrobials. This article reviews many of the important considerations when selecting an antimicrobial for use in neonatal foals. Firstly, we consider general differences in neonatal pharmacology and physiology. Secondly, we review common antimicrobial drugs and their indications. Finally, we review antimicrobial stewardship

Systemic antimicrobial therapy in foals

Antimicrobial agents are commonly used in neonatal foals for the treatment or prevention of sepsis. However, due to concerns about the development of antimicrobial resistance and increasing pressure on veterinarians to rationalise antimicrobial use, we should be trying to reduce the unnecessary use of antimicrobials. This article reviews many of the important considerations when selecting an antimicrobial for use in neonatal foals. Firstly, we consider general differences in neonatal pharmacology and physiology. Secondly, we review common antimicrobial drugs and their indications. Finally, we review antimicrobial stewardship